Work

Randomized phase II trial of cisplatin/gemcitabine with or without LY293111, a multiple eicosonaid pathway modulator, in patients with chemotherapy naïve advanced non-small cell lung carcinoma

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.7024

Authors: P. A. Janne, L. Paz-Ares Rodriguez, M. Gottfried, M. N. Reaume, T. Kaukel, Y. W. Oh, A. Sykes, N. Enas, L. H. Brail, J. Von Pawel

Institutions: Eli Lilly (United States), Dana-Farber Cancer Institute, Asklepios

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2249183791

Cites:

Cited by: 8

Related to: 10